References
- Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet 2003; 361: 2059–2067
- Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317–1320
- Glasker S, Bender BU, Apel TW, et al. The impact of molecular genetic analysis of the VHL gene in patients with hemangioblas-tomas of the central nervous system.] Neurol Neurosurg Psychiatry 1999; 67: 758–762
- Stolle C, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998; 12: 417–423
- Gijtenbeek JM, Jacobs B, Sprenger SH, et al. Analysis of von Hippel-Lindau mutions with comparative genomic hybridization in sporadic and hereditary hemangioblasyomas: Possible genetic heterogeneity. Neurosurg 2002; 97: 977–982
- Zbar B, Kishida T, Chen F, et al. Germline mutation in the von Hippel-Lindau disease (VHL) gene in families from North American, Europe, and Japan. Hum Mutat 1996; 8: 348–357
- Maher ER, Webster AR, Richards FM, et al. Phenotypic expression in von Hippel-Lindau disease: Correlations with germline VHL gene mutations. Med Genet 1996; 33: 328–332
- Jin Zhang, Yi-Ran Huang, Jia-Hua Pan, et al. Germline mutations in Chinese kindreds with von Hippel-Lindau syndrome. Chin] Med Genet 2007; 24: 124–127